NASDAQ : TLX
Telix Pharmaceuticals Limited — Financial statements
Healthcare · Biotechnology · Australia
Last price 9.51 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.22B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Telix Pharmaceuticals Limited (TLX) reported revenue of 890.78M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 890.78M | 803.79M | 516.55M | 332.98M | 108.81M | 5.52M |
| Cost of Revenue | 467.08M | 421.95M | 197.06M | 129.70M | 44.29M | 1.85M |
| Gross Profit | 423.71M | 381.85M | 319.49M | 203.28M | 64.52M | 3.67M |
| Selling, General & Admin | 202.88M | 192.56M | 135.52M | 83.13M | 59.20M | 34.16M |
| Research & Development | 213.49M | 171.25M | 127.93M | 85.31M | 55.06M | 24.82M |
| Other Operating Expenses | -47.93M | -1.25M | 159.00K | -144.00K | 629.38K | |
| Operating Expenses | 368.45M | 362.56M | 263.61M | 168.30M | 114.89M | 62.75M |
| Operating Income | 55.26M | 19.29M | 55.88M | 34.98M | -50.37M | -59.08M |
| Interest Expense | -14.99M | -13.76M | -4.79M | -520.00K | -219.53K | -118.52K |
| Interest & Investment Income | 4.48M | 5.83M | 7.18M | 671.00K | 680.00 | |
| Currency Exchange Gain (Loss) | -563.00K | -563.00K | 11.89M | -734.00K | -759.19K | 1.23M |
| Other Non Operating Income (Expenses) | -29.36M | -27.11M | -19.65M | -8.56M | -4.33M | 10.25M |
| EBT Excluding Unusual Items | 14.83M | -16.32M | 50.52M | 25.83M | -55.68M | -47.71M |
| Merger & Restructuring Charges | -5.75M | |||||
| Asset Writedown | -566.00K | -566.00K | 475.00K | -550.00K | ||
| Other Unusual Items | 14.55M | 11.62M | -7.33M | -22.69M | -11.36M | -10.80M |
| Pretax Income | 28.82M | -5.27M | 37.91M | 2.59M | -67.03M | -58.51M |
| Income Tax Expense | -4.68M | 1.86M | 4.23M | -1.61M | 3.71M | 32.72K |
| Net Income | 33.50M | -7.12M | 33.69M | 4.21M | -70.74M | -58.54M |
| Net Income to Common | 33.50M | -7.12M | 33.69M | 4.21M | -70.74M | -58.54M |
| Shares Outstanding (Basic) | 341.88M | 337.88M | 331.23M | 319.18M | 310.64M | 282.21M |
| Shares Outstanding (Diluted) | 350.71M | 337.88M | 345.19M | 323.71M | 310.64M | 282.21M |
| EPS (Basic) | 0.10 | -0.02 | 0.10 | 0.01 | -0.23 | -0.21 |
| EPS (Diluted) | 0.10 | -0.02 | 0.10 | 0.01 | -0.23 | -0.21 |
| Free Cash Flow | -45.49M | -42.98M | 18.37M | 7.97M | -48.26M | -44.11M |
| Free Cash Flow Per Share | -0.13 | -0.13 | 0.05 | 0.03 | -0.15 | -0.16 |
| Gross Margin | 47.57% | 47.50% | 61.85% | 61.05% | 59.29% | 66.46% |
| Operating Margin | 6.20% | 2.40% | 10.82% | 10.51% | -46.29% | -1,069.60% |
| Profit Margin | 3.76% | -0.89% | 6.52% | 1.26% | -65.01% | -1,059.90% |
| Free Cash Flow Margin | -5.11% | -5.35% | 3.56% | 2.39% | -44.35% | -798.67% |
| EBITDA | 69.81M | 32.46M | 59.63M | 38.16M | -47.30M | -55.79M |
| EBITDA Margin | 7.84% | 4.04% | 11.54% | 11.46% | -43.47% | |
| D&A For EBITDA | 14.55M | 13.17M | 3.75M | 3.19M | 3.07M | 3.29M |
| EBIT | 55.26M | 19.29M | 55.88M | 34.98M | -50.37M | -59.08M |
| EBIT Margin | 6.20% | 2.40% | 10.82% | 10.51% | -46.29% | |
| Effective Tax Rate | 11.16% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 251.91M | 141.87M | 440.00M | 84.30M | 79.07M | 16.02M |
| Cash & Short-Term Investments | 251.91M | 141.87M | 440.00M | 84.30M | 79.07M | 16.02M |
| Accounts Receivable | 163.56M | 129.20M | 86.93M | 44.04M | 26.75M | 530.79K |
| Other Receivables | 6.83M | 9.17M | 12.73M | 5.24M | 4.46M | 14.63M |
| Receivables | 170.39M | 138.37M | 99.65M | 49.28M | 31.21M | 15.16M |
| Inventory | 39.03M | 37.08M | 23.62M | 12.74M | 5.76M | 2.51M |
| Prepaid Expenses | 12.96M | 6.84M | 1.70M | 877.63K | ||
| Other Current Assets | 26.69M | 12.38M | ||||
| Total Current Assets | 488.02M | 330.28M | 570.12M | 158.69M | 117.74M | 34.57M |
| Property, Plant & Equipment | 129.63M | 115.61M | 33.65M | 20.86M | 12.80M | 4.60M |
| Long-Term Investments | 40.41M | 3.68M | 3.77M | |||
| Goodwill | 197.51M | 198.99M | 66.59M | 3.75M | 2.98M | |
| Other Intangible Assets | 387.10M | 393.83M | 191.27M | 75.05M | 36.34M | 37.54M |
| Long-Term Deferred Tax Assets | 85.30M | 59.35M | 28.92M | 13.99M | 2.70M | |
| Other Long-Term Assets | 33.88M | 62.24M | 46.06M | 8.66M | 222.25K | 154.15K |
| Total Assets | 1.36B | 1.16B | 940.38M | 277.26M | 173.56M | 79.85M |
| Accounts Payable | 168.97M | 71.66M | 42.23M | 54.33M | 11.42M | 8.64M |
| Accrued Expenses | 20.29M | 52.63M | 47.94M | 9.53M | 25.23M | 8.48M |
| Short-Term Debt | 13.81K | |||||
| Current Portion of Long-Term Debt | 11.51M | 13.11M | 11.76M | 660.00K | ||
| Current Portion of Leases | 3.92M | 5.55M | 1.55M | 407.00K | 435.67K | 445.72K |
| Current Income Taxes Payable | 33.85M | 30.74M | 30.09M | 13.11M | 4.98M | |
| Current Unearned Revenue | 910.00K | 964.00K | 7.54M | 7.92M | 3.63M | 4.51M |
| Other Current Liabilities | 2.90M | 56.97M | 63.99M | 25.42M | 12.46M | 5.53M |
| Total Current Liabilities | 242.34M | 231.62M | 205.09M | 111.37M | 58.15M | 27.62M |
| Long-Term Debt | 504.88M | 391.91M | 341.81M | 5.95M | 2.25M | |
| Long-Term Leases | 59.56M | 56.53M | 5.04M | 5.25M | 4.41M | 1.39M |
| Long-Term Unearned Revenue | 1.48M | 3.32M | 8.32M | 16.77M | 17.84M | |
| Pension & Post-Retirement Benefits | 607.00K | 444.00K | 305.00K | 212.00K | 146.13K | 95.98K |
| Long-Term Deferred Tax Liabilities | 43.30M | 44.71M | 5.80M | |||
| Other Long-Term Liabilities | 23.49M | 21.90M | 26.08M | 43.51M | 37.45M | 31.33M |
| Total Liabilities | 874.18M | 748.61M | 587.44M | 174.61M | 119.18M | 78.28M |
| Common Stock | 490.92M | 479.96M | 414.01M | 315.18M | 252.14M | 124.22M |
| Retained Earnings | -110.90M | -154.54M | -152.91M | -187.12M | -185.42M | -126.13M |
| Comprehensive Income & Other | 107.65M | 89.95M | 91.84M | -25.41M | -12.34M | 3.48M |
| Shareholders' Equity | 487.68M | 415.38M | 352.94M | 102.64M | 54.38M | 1.57M |
| Total Liabilities & Equity | 1.36B | 1.16B | 940.38M | 277.26M | 173.56M | 79.85M |
| Total Debt | 579.86M | 467.11M | 360.16M | 12.26M | 7.10M | 1.85M |
| Net Cash (Debt) | -327.95M | -325.24M | 79.84M | 72.03M | 71.97M | 14.18M |
| Net Cash Per Share | -0.94 | -0.96 | 0.23 | 0.22 | 0.23 | 0.05 |
| Filing Date Shares Outstanding | 339.78M | 338.78M | 329.55M | 323.96M | 316.71M | 308.20M |
| Total Common Shares Outstanding | 339.78M | 338.78M | 334.73M | 323.73M | 316.34M | 285.07M |
| Working Capital | 245.68M | 98.66M | 365.03M | 47.32M | 59.59M | 6.95M |
| Book Value Per Share | 1.44 | 1.23 | 1.05 | 0.32 | 0.17 | 0.01 |
| Tangible Book Value | -96.94M | -177.45M | 95.08M | 27.59M | 14.29M | -38.95M |
| Tangible Book Value Per Share | -0.29 | -0.52 | 0.28 | 0.09 | 0.05 | -0.14 |
| Land | 18.85M | 11.95M | 6.68M | 1.71M | ||
| Machinery | 28.84M | 6.45M | 1.16M | 1.34M | ||
| Construction In Progress | 12.44M | 9.46M | ||||
| Leasehold Improvements | 4.28M | 2.05M | 1.05M | 273.39K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 33.50M | -7.12M | 33.69M | 4.21M | -70.74M | -58.54M |
| Depreciation & Amortization | 22.32M | 20.95M | 5.28M | 4.16M | 3.66M | 3.76M |
| Other Amortization | 656.00K | 460.00K | ||||
| Asset Writedown & Restructuring Costs | 566.00K | 566.00K | -475.00K | 550.00K | ||
| Stock-Based Compensation | 19.35M | 19.35M | 12.93M | 5.85M | 5.51M | 961.25K |
| Other Operating Activities | -43.18M | -6.28M | 19.08M | 24.02M | 18.77M | 12.59M |
| Change in Accounts Receivable | -20.46M | -20.46M | -37.49M | -18.62M | -13.55M | -5.23M |
| Change in Inventory | -7.64M | -7.64M | -2.13M | -6.55M | -3.41M | -2.05M |
| Change in Accounts Payable | 28.98M | 28.98M | 28.84M | 18.09M | 20.70M | 5.44M |
| Change in Unearned Revenue | -9.13M | -9.13M | -6.23M | -3.43M | -1.91M | -1.96M |
| Change in Other Net Operating Assets | -36.96M | -36.96M | -26.00M | -13.99M | -2.51M | 1.89M |
| Operating Cash Flow | -12.01M | -17.29M | 27.49M | 14.27M | -43.48M | -43.14M |
| Capital Expenditures | -33.48M | -25.69M | -9.12M | -6.31M | -4.78M | -973.61K |
| Cash Acquisitions | -12.78M | -229.03M | -23.20M | -995.00K | -661.32K | |
| Sale (Purchase) of Intangibles | -1.31M | -18.08M | -13.07M | -802.00K | -4.64M | |
| Investment in Securities | -1.07M | -892.00K | -32.91M | -8.70M | ||
| Other Investing Activities | -12.16M | -12.22M | -8.39M | -37.00K | -1.47M | -1.01M |
| Investing Cash Flow | -60.78M | -285.92M | -86.69M | -16.84M | -11.55M | -1.98M |
| Long-Term Debt Issued | 529.00K | 427.90M | 4.19M | 2.05M | ||
| Long-Term Debt Repaid | -6.06M | -2.06M | -1.27M | -867.94K | -680.58K | |
| Lease Payments | -6.03M | -5.24M | -1.32M | -1.27M | -859.10K | -433.36K |
| Net Debt Issued (Repaid) | 115.13M | -5.53M | 425.84M | 2.92M | 1.18M | -680.58K |
| Issuance of Common Stock | 2.50M | 1.81M | 662.00K | 4.17M | 123.05M | 2.75M |
| Other Financing Activities | -9.71M | -5.31M | ||||
| Financing Cash Flow | 117.63M | -3.72M | 416.79M | 7.09M | 118.92M | 2.07M |
| Foreign Exchange Rate Adjustments | -87.00K | 8.80M | -1.89M | 992.00K | 203.22K | 2.40M |
| Net Cash Flow | 44.75M | -298.13M | 355.70M | 5.52M | 64.09M | -40.65M |
| Free Cash Flow | -45.49M | -42.98M | 18.37M | 7.97M | -48.26M | -44.11M |
| Free Cash Flow Margin | -5.11% | -5.35% | 3.56% | 2.39% | -44.35% | -798.67% |
| Free Cash Flow Per Share | -0.13 | -0.13 | 0.05 | 0.03 | -0.15 | -0.16 |
| Levered Free Cash Flow | -62.60M | -36.67M | 53.71M | 41.26M | -20.88M | -27.18M |
| Unlevered Free Cash Flow | -53.23M | -28.07M | 56.71M | 41.58M | -20.74M | -27.11M |
| Free Cash Flow After Leases | -51.51M | -48.22M | 17.06M | 6.70M | -49.12M | -44.55M |
| Cash Interest Paid | 14.79M | 13.70M | 3.09M | 385.00K | 277.31K | 137.43K |
| Cash Income Tax Paid | 32.75M | 21.30M | 2.03M | 6.86M | -11.30M | -8.81M |
| Change in Working Capital | -45.22M | -45.22M | -43.01M | -24.51M | -684.43K | -1.91M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.15B | 2.53B | 5.10B | 2.22B | 1.56B | 1.61B |
| Enterprise Value | 3.48B | 2.75B | 5.04B | 2.14B | 1.48B | 1.57B |
| Last Close Price | 9.10 | 7.49 | 15.40 | |||
| PE Ratio | 94.77 | 151.34 | 528.32 | |||
| PS Ratio | 3.51 | 3.15 | 9.87 | 6.68 | 14.37 | 290.85 |
| PB Ratio | 6.41 | 6.09 | 14.44 | 21.66 | 28.75 | 1,023.78 |
| P/TBV Ratio | 53.62 | 80.58 | 109.39 | |||
| P/FCF Ratio | 277.46 | 279.08 | ||||
| P/OCF Ratio | 185.44 | 155.76 | ||||
| EV/Sales Ratio | 3.88 | 3.42 | 9.75 | 6.43 | 13.62 | 284.54 |
| EV/EBITDA Ratio | 49.57 | 84.57 | 84.48 | 56.13 | ||
| EV/EBIT Ratio | 62.62 | 142.34 | 90.15 | 61.25 | ||
| EV/FCF Ratio | 274.21 | 268.94 | ||||
| Debt / Equity Ratio | 1.19 | 1.12 | 1.02 | 0.12 | 0.13 | 1.18 |
| Debt / EBITDA Ratio | 7.47 | 11.61 | 5.89 | 0.31 | ||
| Debt / FCF Ratio | 19.60 | 1.54 | ||||
| Net Debt / Equity Ratio | 0.67 | 0.78 | -0.23 | -0.70 | -1.32 | -9.04 |
| Net Debt / EBITDA Ratio | 4.70 | 10.02 | -1.34 | -1.89 | 1.52 | 0.25 |
| Net Debt / FCF Ratio | -7.21 | -7.57 | -4.34 | -9.04 | 1.49 | 0.32 |
| Asset Turnover | 0.70 | 0.76 | 0.85 | 1.48 | 0.88 | 0.06 |
| Inventory Turnover | 12.58 | 13.90 | 10.84 | 14.01 | 10.92 | 1.25 |
| Quick Ratio | 1.74 | 1.21 | 2.63 | 1.20 | 1.90 | 1.13 |
| Current Ratio | 2.01 | 1.43 | 2.78 | 1.43 | 2.02 | 1.25 |
| Return on Equity (ROE) | 7.36% | -1.85% | 14.79% | 5.36% | -253.34% | -198.36% |
| Return on Assets (ROA) | 2.71% | 1.15% | 5.74% | 9.69% | -25.37% | -37.95% |
| Return on Invested Capital (ROIC) | 6.78% | 3.81% | 32.69% | 114.26% | ||
| Return on Capital Employed (ROCE) | 4.90% | 2.10% | 7.60% | 21.10% | -43.60% | -113.10% |
| Earnings Yield | 1.06% | -0.28% | 0.66% | 0.19% | -4.53% | -3.64% |
| FCF Yield | -1.45% | -1.70% | 0.36% | 0.36% | -3.09% | -2.75% |
| Buyback Yield / Dilution | -2.75% | 2.12% | -6.64% | -4.21% | -10.08% | -9.69% |